Holm R - Search Results

1

The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma--differences in histological subtypes.

Eide HA, Halvorsen AR, Bjaanæs MM, Piri H, Holm R, Solberg S, Jørgensen L, Brustugun OT, Kiserud CE, Helland Å. Eide HA, et al. Among authors: holm r. BMC Cancer. 2016 Feb 8;16:71. doi: 10.1186/s12885-016-2104-9. BMC Cancer. 2016. PMID: 26858029 Free PMC article.

2

Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load.

Helland A, Karlsen F, Due EU, Holm R, Kristensen G, Børresen-Dale Al. Helland A, et al. Among authors: holm r. Br J Cancer. 1998 Jul;78(1):69-72. doi: 10.1038/bjc.1998.444. Br J Cancer. 1998. PMID: 9662253 Free PMC article.

3

PIK3CA mutations in advanced ovarian carcinomas.

Wang Y, Helland A, Holm R, Kristensen GB, Børresen-Dale AL. Wang Y, et al. Among authors: holm r. Hum Mutat. 2005 Mar;25(3):322. doi: 10.1002/humu.9316. Hum Mutat. 2005. PMID: 15712344

4

Protein expression and prognostic value of genes in the erb-b signaling pathway in advanced ovarian carcinomas.

Wang Y, Kristensen GB, Helland A, Nesland JM, Børresen-Dale AL, Holm R. Wang Y, et al. Among authors: holm r. Am J Clin Pathol. 2005 Sep;124(3):392-401. doi: 10.1309/BL7E-MW66-LQX6-GFRP. Am J Clin Pathol. 2005. PMID: 16191507

5

TP53 gene mutations and protein accumulation in primary vaginal carcinomas.

Skomedal H, Kristensen G, Helland A, Nesland JM, Kooi S, Børresen AL, Holm R. Skomedal H, et al. Among authors: holm r. Br J Cancer. 1995 Jul;72(1):129-33. doi: 10.1038/bjc.1995.288. Br J Cancer. 1995. PMID: 7599041 Free PMC article.

6

TP53 mutations in early-stage ovarian carcinoma, relation to long-term survival.

Wang Y, Helland A, Holm R, Skomedal H, Abeler VM, Danielsen HE, Tropé CG, Børresen-Dale AL, Kristensen GB. Wang Y, et al. Among authors: holm r. Br J Cancer. 2004 Feb 9;90(3):678-85. doi: 10.1038/sj.bjc.6601537. Br J Cancer. 2004. PMID: 14760384 Free PMC article.

7

Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers.

Helland Å, Anglesio MS, George J, Cowin PA, Johnstone CN, House CM, Sheppard KE, Etemadmoghadam D, Melnyk N, Rustgi AK, Phillips WA, Johnsen H, Holm R, Kristensen GB, Birrer MJ; Australian Ovarian Cancer Study Group; Pearson RB, Børresen-Dale AL, Huntsman DG, deFazio A, Creighton CJ, Smyth GK, Bowtell DD. Helland Å, et al. Among authors: holm r. PLoS One. 2011 Apr 13;6(4):e18064. doi: 10.1371/journal.pone.0018064. PLoS One. 2011. PMID: 21533284 Free PMC article.

8

High expression of wee1 is associated with malignancy in vulvar squamous cell carcinoma patients.

Magnussen GI, Hellesylt E, Nesland JM, Trope CG, Flørenes VA, Holm R. Magnussen GI, et al. Among authors: holm r. BMC Cancer. 2013 Jun 14;13:288. doi: 10.1186/1471-2407-13-288. BMC Cancer. 2013. PMID: 23767999 Free PMC article.

9

Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteri.

Holm R, Skomedal H, Helland A, Kristensen G, Børresen AL, Nesland JM. Holm R, et al. J Pathol. 1993 Jan;169(1):21-6. doi: 10.1002/path.1711690105. J Pathol. 1993. PMID: 8433212

10

Allelic imbalance at chromosome region 11q23 in cervical carcinomas.

Skomedal H, Helland A, Kristensen GB, Holm R, Børresen-Dale AL. Skomedal H, et al. Among authors: holm r. Eur J Cancer. 1999 Apr;35(4):659-63. doi: 10.1016/s0959-8049(98)00413-4. Eur J Cancer. 1999. PMID: 10492643

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

836 results

Search Page